Malignant peripheral nerve sheath tumours in neurofibromatosis type 1
Standard
Malignant peripheral nerve sheath tumours in neurofibromatosis type 1 : MRI supports the diagnosis of malignant plexiform neurofibroma. / Mautner, V F; Friedrich, R E; von Deimling, A; Hagel, C; Korf, B; Knöfel, M T; Wenzel, R; Fünsterer, C.
in: NEURORADIOLOGY, Jahrgang 45, Nr. 9, 01.09.2003, S. 618-25.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Malignant peripheral nerve sheath tumours in neurofibromatosis type 1
T2 - MRI supports the diagnosis of malignant plexiform neurofibroma
AU - Mautner, V F
AU - Friedrich, R E
AU - von Deimling, A
AU - Hagel, C
AU - Korf, B
AU - Knöfel, M T
AU - Wenzel, R
AU - Fünsterer, C
PY - 2003/9/1
Y1 - 2003/9/1
N2 - Plexiform neurofibroma (PNF) is a typical feature of neurofibromatosis 1 (NF1). About 10% of patients with NF1 develop malignant peripheral nerve-sheath tumours (MPNST), usually arising from PNF, and this is the major cause of poor survival. A better prognosis can be achieved if the tumours are diagnosed at an early stage. Our objective was to establish MRI criteria for MPNST and to test their usefulness in detecting early malignant change in PNF. MRI was performed on 50 patients with NF1 and nerve-sheath tumours, of whom seven had atypical pain, tumour growth or neurological deficits indicative of malignancy; the other 43 were asymptomatic. On MRI all seven symptomatic patients had inhomogeneous lesions, due to necrosis and haemorrhage and patchy contrast enhancement. In one patient, the multiplicity of confluent tumours with inhomogeneous areas in addition to central lesions did not allow exclusion of malignancy. Only three of the 43 asymptomatic patients had comparable changes; the other 40 patients had tumours being of relatively homogeneous structure on T1- and T2-weighted images before and after contrast enhancement. All three asymptomatic patients with inhomogeneous lesions were shown to have MPNST.
AB - Plexiform neurofibroma (PNF) is a typical feature of neurofibromatosis 1 (NF1). About 10% of patients with NF1 develop malignant peripheral nerve-sheath tumours (MPNST), usually arising from PNF, and this is the major cause of poor survival. A better prognosis can be achieved if the tumours are diagnosed at an early stage. Our objective was to establish MRI criteria for MPNST and to test their usefulness in detecting early malignant change in PNF. MRI was performed on 50 patients with NF1 and nerve-sheath tumours, of whom seven had atypical pain, tumour growth or neurological deficits indicative of malignancy; the other 43 were asymptomatic. On MRI all seven symptomatic patients had inhomogeneous lesions, due to necrosis and haemorrhage and patchy contrast enhancement. In one patient, the multiplicity of confluent tumours with inhomogeneous areas in addition to central lesions did not allow exclusion of malignancy. Only three of the 43 asymptomatic patients had comparable changes; the other 40 patients had tumours being of relatively homogeneous structure on T1- and T2-weighted images before and after contrast enhancement. All three asymptomatic patients with inhomogeneous lesions were shown to have MPNST.
KW - Adolescent
KW - Adult
KW - Diagnosis, Differential
KW - Female
KW - Hemorrhage
KW - Humans
KW - Magnetic Resonance Imaging
KW - Male
KW - Middle Aged
KW - Necrosis
KW - Nerve Sheath Neoplasms
KW - Neurofibromatosis 1
KW - Pain
KW - Sensitivity and Specificity
U2 - 10.1007/s00234-003-0964-6
DO - 10.1007/s00234-003-0964-6
M3 - SCORING: Journal article
C2 - 12898075
VL - 45
SP - 618
EP - 625
JO - NEURORADIOLOGY
JF - NEURORADIOLOGY
SN - 0028-3940
IS - 9
ER -